Total Payments
$2,146
2024 Payments
$867.28
Companies
19
Transactions
138
Medicare Patients
1,834
Medicare Billing
$848,780
Payment Breakdown by Category
Food & Beverage$2,127 (99.1%)
Education$19.76 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,127 | 135 | 99.1% |
| Education | $19.76 | 3 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $420.74 | 45 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $281.14 | 17 | $0 (2024) |
| Relypsa, Inc. | $203.32 | 12 | $0 (2020) |
| Amgen Inc. | $170.06 | 10 | $0 (2024) |
| Inari Medical, Inc. | $162.23 | 1 | $0 (2023) |
| Ardelyx, Inc. | $154.52 | 15 | $0 (2024) |
| Medtronic, Inc. | $126.93 | 1 | $0 (2022) |
| Vifor Pharma, Inc. | $114.30 | 6 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $112.35 | 6 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $80.46 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $867.28 | 55 | Novartis Pharmaceuticals Corporation ($264.72) |
| 2023 | $418.37 | 18 | Inari Medical, Inc. ($162.23) |
| 2022 | $447.92 | 27 | Horizon Therapeutics plc ($207.01) |
| 2021 | $129.17 | 20 | Horizon Therapeutics plc ($129.17) |
| 2020 | $164.78 | 10 | Relypsa, Inc. ($110.23) |
| 2019 | $64.70 | 5 | Relypsa, Inc. ($38.87) |
| 2018 | $54.22 | 3 | Relypsa, Inc. ($54.22) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Hyperkalemia | ||||||
| 12/17/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/13/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.22 | General |
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Cardio-renal | ||||||
| 11/28/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $31.24 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $12.55 | General |
| 11/15/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $9.21 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/07/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Nephrology | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $14.05 | General |
| 11/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $19.19 | General |
| 10/24/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $2.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Hyperkalemia | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $13.33 | General |
| 09/24/2024 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: Oncology | ||||||
| 09/23/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $16.27 | General |
| 09/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/03/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.87 | General |
| 08/19/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Nephrology | ||||||
| 08/14/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/14/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $4.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 387 | 1,033 | $356,737 | $163,408 |
| 2022 | 10 | 362 | 1,069 | $387,690 | $179,506 |
| 2021 | 9 | 484 | 1,486 | $501,825 | $235,751 |
| 2020 | 11 | 601 | 1,992 | $664,670 | $270,116 |
Total Patients
1,834
Total Services
5,580
Medicare Billing
$848,780
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 40 | 252 | $150,444 | $73,334 | 48.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 30 | 105 | $52,920 | $25,825 | 48.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 203 | $46,893 | $19,424 | 41.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 50 | 151 | $32,163 | $15,036 | 46.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 43 | 122 | $18,056 | $8,136 | 45.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 44 | 51 | $21,267 | $7,159 | 33.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 31 | 84 | $12,516 | $5,042 | 40.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 30 | $9,210 | $4,515 | 49.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $8,472 | $2,911 | 34.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $4,796 | $2,027 | 42.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 40 | 313 | $186,861 | $93,388 | 50.0% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 32 | 96 | $48,384 | $23,019 | 47.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 95 | 201 | $46,431 | $19,605 | 42.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 49 | 175 | $37,275 | $15,134 | 40.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 42 | 56 | $23,352 | $9,192 | 39.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 39 | 126 | $18,648 | $7,576 | 40.6% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 12 | 19 | $7,448 | $3,229 | 43.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $7,060 | $2,912 | 41.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 22 | 45 | $6,705 | $2,760 | 41.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 18 | $5,526 | $2,691 | 48.7% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 50 | 364 | $217,215 | $111,062 | 51.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 93 | 384 | $81,792 | $33,869 | 41.4% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 39 | 114 | $57,456 | $28,741 | 50.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 94 | 206 | $47,586 | $22,129 | 46.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 88 | 105 | $43,785 | $17,036 | 38.9% |
About Dr. Edwin Chin, MD
Dr. Edwin Chin, MD is a Internal Medicine healthcare provider based in Burien, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487614830.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edwin Chin, MD has received a total of $2,146 in payments from pharmaceutical and medical device companies, with $867.28 received in 2024. These payments were reported across 138 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,127).
As a Medicare-enrolled provider, Chin has provided services to 1,834 Medicare beneficiaries, totaling 5,580 services with total Medicare billing of $848,780. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Nephrology
- Location Burien, WA
- Active Since 03/27/2006
- Last Updated 10/09/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1487614830
Products in Payments
- KRYSTEXXA (Biological) $520.06
- Veltassa (Drug) $317.62
- FLOWTRIEVER CATHETER, S (Device) $162.23
- IBSRELA (Drug) $154.52
- ELLIPSYS VASCULAR ACCESS SYSTEM (Device) $126.93
- TARPEYO (Drug) $112.35
- JYNARQUE (Drug) $80.46
- Kerendia (Drug) $70.24
- Velphoro (Drug) $38.08
- Kyprolis (Drug) $29.75
- AURYXIA (Drug) $25.83
- GATTEX (Drug) $24.77
- Ozempic (Drug) $24.57
- Thiola (Drug) $21.95
- LOKELMA (Drug) $20.67
- LUPKYNIS (Drug) $20.28
- TAVNEOS (Drug) $14.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Burien
Daniel Ziperovich, Md, MD
Internal Medicine — Payments: $15,879
Internal Medicine $15,879
Dr. Chatchawan Piyaskulkaew, M.d, M.D
Internal Medicine — Payments: $1,508
Internal Medicine $1,508
Dr. Scott Greenspahn, M.d, M.D
Internal Medicine — Payments: $1,161
Internal Medicine $1,161
Dr. Richard Olstein, M.d, M.D
Internal Medicine — Payments: $869.77
Internal Medicine $869.77
Dr. Harry Pierce, Do, DO
Internal Medicine — Payments: $351.14
Internal Medicine $351.14
Niharika Chimalakonda, Md, MD
Internal Medicine — Payments: $292.08
Internal Medicine $292.08